|
||
© The Rockefeller University Press,
0021-9525/2001/12/1287 $5.00
The Journal of Cell Biology, Volume 155, Number 7, December 24, 2001 1287-1296
Article |
MuSK induces in vivo acetylcholine receptor clusters in a ligand-independent manner
Address correspondence to Dr. Veit Witzemann, Abt. Zellphysiologie, Max-Planck-Institut für Medizinische Forschung, Jahnstr. 29, 69120 Heidelberg, Germany. Tel.: (49) 6221-486-475. Fax: (49) 6221-486-459. E-mail: witzemann{at}sunny.mpimf-heidelberg.mpg.de
| Abstract |
|---|
|
|
|---|
Muscle-specific receptor tyrosine kinase (MuSK) is required for the formation of the neuromuscular junction. Using direct gene transfer into single fibers, MuSK was expressed extrasynaptically in innervated rat muscle in vivo to identify its contribution to synapse formation. Spontaneous MuSK kinase activity leads, in the absence of its putative ligand neural agrin, to the appearance of
-subunitspecific transcripts, the formation of acetylcholine receptor clusters, and acetylcholinesterase aggregates. Expression of kinase-inactive MuSK did not result in the formation of acetylcholine receptor (AChR) clusters, whereas a mutant MuSK lacking the ectodomain did induce AChR clusters. The contribution of endogenous MuSK was excluded by using genetically altered mice, where the kinase domain of the MuSK gene was flanked by loxP sequences and could be deleted upon expression of Cre recombinase. This allowed the conditional inactivation of endogenous MuSK in single muscle fibers and prevented the induction of ectopic AChR clusters. Thus, the kinase activity of MuSK initiates signals that are sufficient to induce the formation of AChR clusters. This process does not require additional determinants located in the ectodomain.
Key Words: gene transfer; muscle; rat; neuromuscular junction; MuSK
| Introduction |
|---|
|
|
|---|
The steps that lead to elevated levels of MuSK at synaptic sites, its interactions with agrin and rapsyn, and the signals that cause clustering of postsynaptic proteins remain elusive. Also, most experiments so far were done in cell culture systems where MuSK-dependent signaling has been assayed in the presence of the putative ligand, neural agrin. In such experiments it is not possible to exclude a direct contribution of the ligand itself to the observed effects attributed solely to the activation of MuSK. Therefore, we used ectopic expression in single muscle fibers (Jones et al., 1997; Sander et al., 2000) to analyze the function of MuSK in the formation of the postsynaptic apparatus in vivo and independent of agrin. The results show that ectopic expression of MuSK induces the formation of postsynaptic-like specializations, including the appearance of adult-type AChR
subunit transcripts and the aggregation of synaptic proteins such as AChR and acetylcholinesterase (AChE). AChR clusters were also induced by a truncated MuSK form lacking the ectodomain or a form where the ectodomain was replaced by GFP. To exclude any contribution of endogenous MuSK, we employed mutant mice (Hesser, 2000; unpublished data) where MuSK was inactivated conditionally upon expression of transgenic Cre recombinase by direct gene transfer. High resolution analysis revealed that rapsyngreen fluorescent proteins (GFPs), but not MuSKGFP fusion proteins, were colocalized with AChR clusters. This suggests that a direct physical interaction between rapsyn and MuSK may not be a prerequisite for the formation of AChR clusters. The results show that MuSK activity initiates signals that lead to the formation of AChR clusters, a process which does not require ligand-dependent activation or ectodomain regions. Part of this work was presented in abstract form.
| Results |
|---|
|
|
|---|
|
|
|
subunit transcript levels were elevated. Since the
subunit transcripts of normal innervated muscle are restricted to synaptic nuclei and are not expressed in extrasynaptic fiber regions (Brenner et al., 1990), their appearance was taken as evidence of the expression of new AChR. As shown in Fig. 1 E, AChR were located in the plasma membrane of the injected muscle fiber and appeared to form aggregates of varying size. In situ hybridization of the cross-section shown in Fig. 1 E revealed ectopic expression of
subunit transcripts in fibers containing MuSK-induced AChR clusters (Fig. 1 F). Positive hybridization signals were never observed outside the AChR cluster regions of injected fibers nor in adjacent noninjected fibers (Fig. 1 F), suggesting that MuSK-dependent signals mediate either directly or indirectly expression of
subunit gene transcripts and formation of AChR clusters at the sites of MuSK DNA injection.
MuSK kinase activity is required for induction of AChR clusters
Expression of the kinase-inactive mutant MuSKK608A (Glass et al., 1997) in single muscle fibers confirmed that no AChR clusters were induced (Fig. 2). To visualize and demonstrate directly the expression of recombinant MuSK in the injected muscle fibers, we fused GFP with MuSK (MuSKGFP) and with the kinase-inactive mutant MuSKK608A (MuSKK608AGFP), as schematically summarized in Fig. 2. Fig. 3, A and D, demonstrate that both constructs were expressed with similar efficiency. MuSKGFP gave rise to AChR clusters which were clearly identified with rhodamine-labeled
-bungarotoxin (r-bgt) (Fig. 3 B). The overlay of the green and red fluorescence confocal images (Fig. 3 C) shows that MuSKGFP was not strictly colocalized with the AChR clusters. Statistical analysis revealed that in all transgene-expressing fibers, as marked by GFP, AChR clusters were formed (Fig. 3 F). No AChR clusters, however, were induced by the kinase-inactive mutant MuSKK608AGFP (Fig. 3, D, E, and G and Fig. 2), demonstrating that kinase activity is required for the induction of AChR clusters. Rapsyn coinjected with the MuSK mutant was unable to form AChR clusters.
|
Since agrin-mediated AChR clustering requires MuSK (Glass et al., 1996; Zhou et al., 1999), AChR clusters should not appear in fibers lacking endogenous MuSK. Therefore, muscle fibers were injected with Cre DNA together with agrin and nGFP. The maximum projection of a confocal image series in Fig. 4 C demonstrates successful gene transfer by the appearance of agrin-induced AChR clusters. Cross-sections of single confocal images (unpublished data) as well as the reconstructed xz projection (Fig. 4 D) of the confocal image series (Fig. 4 C) demonstrated clearly that the Cre-injected fibers, identified by nGFP, were not surrounded by r-bgt fluorescence and thus had not formed AChR clusters. However, AChR clusters were located on fibers adjacent to or in the vicinity of the injected fibers. Thus, the locally restricted gene knock-out of MuSK in the Cre-injected muscle fibers inhibited agrin-mediated AChR cluster formation.
To strengthen the observation that AChR cluster formation was completely prevented in muscle fibers expressing Cre, we developed an additional bioassay using rapsynGFP. In cell culture experiments it has been shown previously that rapsynGFP forms fluorescently labeled complexes with AChR (Ramarao and Cohen, 1998). If such complexes were also formed in rapsynGFP-injected muscle fibers, one could directly and reliably monitor the appearance of AChR clusters. In fact, coinjecting rapsynGFP with agrin DNA resulted in the appearance of AChR clusters that were exactly colocalized with rapsynGFP (Fig. 5 A) and demonstrated that induction and aggregation of AChR can be readily detected and assigned to the injected muscle fiber. Transgenically expressed rapsynGFP is therefore a specific and sensitive marker to monitor the appearance of newly formed AChR clusters in vivo. We never observed rapsynGFPAChR clusters in Cre-expressing fibers (Fig. 5 B), demonstrating that local, Cre-mediated DNA recombination in single muscle fibers efficiently inactivated endogenous MuSK and thus prevented agrin-induced activation of AChR expression.
|
Ectodomain of transgenic MuSK is not required for induction of AChR clustering
There is evidence that MuSK signaling requires the ectodomain of MuSK (Apel et al., 1997; Glass et al., 1997). To determine whether MuSK-induced AChR clustering requires the ectodomain, we constructed a mutant lacking the complete extracellular region (
ectoMuSK; see Fig. 2). Fig. 6 A shows several representative AChR cluster patterns induced by transgenic MuSK. The number and size of the AChR clusters vary to some extent and is probably due to the variable amounts of MuSK expressed upon injection. The expression of
ectoMuSK led to the formation of AChR clusters (Fig. 6 B), which were comparable to the clusters induced by full length MuSK. Again, to prove successful expression of the transgene in the injected muscle fibers, the
ectoMuSK construct was fused with GFP where GFP replaced the ectodomain (
ectoMuSKGFP; see Fig. 2). Injection of this DNA led to efficient expression of
ectoMuSKGFP, which induced AChR clusters (Fig. 6 C). The kinase-inactive mutant
ectoMuSKK608AGFP (Fig. 2) was also expressed efficiently, but was unable to induce AChR clusters (Fig. 6 D). Thus, deletion of the ectodomain does not interfere with MuSK's ability to induce aggregation of AChR.
|
ectoMuSKGFP was expressed efficiently (Fig. 7 A) and induced the appearance of AChR clusters (Fig. 7 B). Since endogenous MuSK had been inactivated by Cre, this observation confirms that the ectodomain of MuSK is not an integral component of the mechanisms underlying MuSK-induced AChR expression. The overlay of green and red fluorescence images (Fig. 7 C) suggests that
ectoMuSKGFP is not colocalized with r-bgtlabeled AChR.
|
ectoMuSKGFP (Fig. 7 C), it appeared that the two proteins were not strictly colocalized on the surface of the muscle fibers and MuSKGFP fusion proteins were observed outside of AChR clusters and vice versa. This was surprising in view of the current model, in which the ectodomain of MuSK has to be structurally linked to AChR. Therefore, one would expect that a significant portion of the AChR clusters overlaps with the GFP-labeled MuSK molecules. Rapsyn is thought to interconnect AChR and MuSK via the hypothetical linker RATL (Apel et al., 1997). Therefore, we analyzed at higher resolution whether rapsyn was distributed like MuSK or was associated more strictly with AChR (as indicated already in Fig. 5). MuSK and rapsynGFP were injected ectopically to induce AChR clusters and the distribution of rapsynGFP relative to AChR clusters was analyzed by confocal microscopy. Single sections revealed that rapsynGFP was strictly colocalized with AChR stained by r-bgt (Fig. 8, AC). In contrast, when MuSKGFP and rapsyn were injected, MuSKGFP displayed a different distribution and was spatially distinct from AChR clusters (Fig. 8, EG).
|
| Discussion |
|---|
|
|
|---|
subunit gene transcripts at the site of gene transfer. Furthermore, AChE aggregates were colocalized with the AChR clusters. So far, no kinase-signaling pathways have been detected that respond to agrin/MuSK activation. However, the fact that overexpression of MuSK in the absence of neural agrin leads to the ectopic appearance of
subunit mRNA indicates that MuSK-mediated signals could influence gene transcription of the AChR subunit genes and possibly other synaptically expressed genes. Whether this gene induction is directly dependent on MuSK kinase activity or on proteins that bind to activated MuSK (Zhou et al., 1999; Herbst and Burden, 2000) remains to be investigated. There is also the possibility that signaling was indirectly mediated by erbB receptors, which appear to become concentrated at the MuSK scaffold (Burden, 1998; Meier et al., 1998). Recent findings showed that erbB3-deficient mice (Riethmacher et al., 1997), as well as erbB2-deficient mice with a heart-specific erbB2 rescue (Morris et al., 1999), display only minor deficits in early postsynaptic development, suggesting that erbB receptor kinase signaling may not be linked to MuSK to activate AChR subunit gene expression. The MuSK kinase signal is thought not to be sufficient to elicit MuSK action (Glass et al., 1997). Additional domains located in the extracellular region of MuSK appear to be required for the clustering of AChR. The ectodomain mediates agrin-dependent activation via the putative receptor MASC and may interact physically with a hypothetical linker, RATL, to allow MuSK to recruit rapsynAChR complexes to a primary scaffold in the postsynaptic membrane (Apel et al., 1997). However, in myotubes cultured from MuSK-/- mutant mice it was observed that AChR clusters are also induced in a ligand-independent manner by MuSK, even without being colocalized with AChR clusters (Zhou et al., 1999). Using cultured MuSK-/- myotubes, the authors demonstrated that formation of agrin-induced as well as spontaneous AChR clusters requires MuSK.
Gene transfer experiments in single muscle fibers demonstrate now that AChR clusters can be induced by spontaneous MuSK kinase activity in vivo. Since the AChR-inducing activites of MuSK and
ectoMuSK are similar, the clustering process appears not to require additional signals mediated by the ectodomain of MuSK. Jones et al. (1999) induced AChR clusters in muscle fibers by expressing transgenic MuSK chimeras. They found endogenous MuSK associated with the ectopic AChR clusters and concluded that endogenous MuSK, recruited by the transgenic kinase activity, induced AChR clustering via its ectodomain. If the ectodomain was actually required for the formation of AChR clusters one would assume that expression of transgenic full length MuSK, which would not need to recruit endogenous MuSK, was more potent in the induction of AChR clusters than the truncated
ectoMuSK mutant. However, this was not the case, indicating that kinase activity is sufficient to induce AChR clusters.
Nevertheless, endogenous MuSK has to be inactivated to exclude any contribution to the observed changes induced by transgenic MuSK and MuSK mutants. Conditional MuSK gene knock out has been achieved in MuSKloxP/- mice by expressing transgenic Cre. Using the agrin-mediated formation of ectopic AChR clusters as bioassay we showed that endogenous MuSK is inactivated, which prevents the formation of ectopic AChR clusters. The fact that the local MuSK gene knock out is rescued by transgenic MuSK supports the view that agrin requires MuSK to induce AChR clusters. The inactivation of endogenous MuSK, combined with the expression of MuSK mutants lacking the entire ectodomain, demonstrates in addition that the ectodomain of MuSK can be deleted or replaced by GFP without obvious effects on the ability to induce AChR clusters. The apparently ligand-independent activation of MuSK is thus sufficient to initiate signals that lead to the formation of AChR clusters and postsynaptic-like specializations. As there are only very few preexisting AChR in extrasynaptic regions of innervated muscle fibers, it is assumed that transgenic MuSK leads to the production of new AChR which are then organized into clusters.
The AChR clusters induced upon expression of MuSK or of MuSK and rapsyn together do not differ significantly in size and shape, indicating that the endogenous pool of rapsyn is sufficient for the formation of ectopic AChR clusters. In heterologous expression systems transgenic rapsyn self-aggregates and promotes clustering of AChR when both proteins are coexpressed (Froehner et al., 1990; Phillips et al., 1991). However, expression of rapsyn in ectopic muscle fiber regions does not result in the appearance of AChR clusters, demonstrating that AChR are not simply recruited and clustered from preexisting AChR by transgenic rapsyn, as may be the case in cultured myotubes.
AChR clusters are also induced by agrin in MuSK-/-cell cultures transfected with MuSK mutants lacking the putative RATL binding domain, indicating that MuSKrapsyn/RATL interactions are dispensable for at least some aspects of MuSK function (Zhou et al., 1999). The finding that the GFP-labeled kinase and AChR clusters can be spatially distinct in muscle fibers lends support to the view that the rapsyn/AChR clustering process does not require a structural linker protein between MuSK and AChR. MuSK signals act locally restricted, since transgenic MuSKGFP is not transported over a wide distance but is expressed within a spatially limited range at the DNA injection site, where it determines formation of AChR clusters.
These results lead to the hypothesis that MuSK signals mediate an increased expression of AChR subunits which are assembled to form complexes with endogenous rapsyn. Postsynaptic specializations develop only at sites where MuSK is concentrated, under natural conditions at contact sites of nerve and muscle. The clustering of AChR that we observe upon transgenic expression of MuSK may thus reflect a physiological process occurring before synapse formation. It was reported that in topoisomerase-deficient mice, motor axons are not developed. Yet, there are AChR concentrated in the central region of the diaphragm muscle (Yang et al., 2000). This suggests that the accumulation of AChR occurs in the absence of neuronal factors. However, AChR are not accumulated in muscle fibers lacking MuSK, although motor axons are present in these muscles (DeChiara et al., 1996), demonstrating that MuSK is required for the accumulation of AChR. While this paper was under review, two papers were published where AChR expression was investigated in embryonic mutant mice lacking agrin, MuSK, rapsyn, and/or motor nerves (Lin et al., 2001; Yang et al., 2001). The results show that MuSK and rapsyn are required for early postsynaptic differentiation which occurs in absence of agrin or motor axons. In this scenario (Fig. 9) MuSK accumulates in the central, developmentally oldest region of muscle fibers. Reaching a critical threshold, spontaneous kinase activity is strong enough to induce accumulations of AChR, similar to those we observe upon transgenic expression of MuSK. In a second step, agrin (and possibly other factors) released by incoming motor axons might favor the formation of denser accumulations by locally activating MuSK. The local action of MuSK and the local secretion of agrin might reinforce each other to generate the extreme density of postsynaptic proteins encountered at the neuromuscular junction.
|
| Materials and methods |
|---|
|
|
|---|
MuSK.
MuSK-cDNA was isolated by RT-PCR and cloned with EcoRI (5') and XbaI (3') in pRK5 according to Hesser et al. (1999).
MuSKGFP.
A XhoI cloning site was introduced into the MuSK cDNA at nucleotides 100105 and an EcoRV site at nucleotides 106111. Both mutations were introduced by site-directed mutagenesis in two steps using PCR (QuickChange Site-directed Mutagenesis Kit; Stratagene). GFP was amplified by PCR using the corresponding primers to ligate the product into the mutated MuSK cDNA. The following primer pair was used for PCR amplification of GFP: the 5' sense primer was AACTCGAGAGCAAGGGCGAGGAACTGTTC, adding an XhoI site and at the same time replacing the start codon; the 3' antisense primer was TTGATATCGTACAGCTCGTCCATGCCATG, adding an EcoRV site and replacing the stop codon of GFP. The ligation of the GFP with XhoI (5') and EcoRV (3') in the mutated MuSK (XhoI, EcoRV) resulted in MuSKGFP.
ectoMuSK.
XhoI cloning sites were introduced into the MuSK cDNA at nucleotides 100105 and at nucleotides 1,4321,437. These mutations were also introduced by site-directed mutagenesis. Restriction with XhoI and religation resulted in a MuSK mutant construct where the entire ectodomain but not the signal peptide was deleted.
ectoMuSKGFP.
The PCR-amplified GFP sequence, flanked by XhoI sites, was inserted at the XhoI site of
ectoMuSK as described above to yield
ectoMuSKGFP, where the ectodomain excluding the signal peptide was replaced by GFP. The following primer pair was used for PCR amplification of GFP: the 5' sense primer was AACTCGAGAGCAAGGGCGAGGAACTGTTC, adding an XhoI site and replacing the start codon; the 3' antisense primer was TTCTCGAGGTACAGCTCGTCCATGCCATG, also adding an XhoI and replacing the stop codon of GFP.
MuSKK608A.
MuSK cDNA in the pRK5 vector was mutated by replacing K608 to A608 using the site-directed mutagenesis kit from Stratagene. The kinase activitydeficient mutant MuSKK608A was described by Glass et al. (1997).
ectoMuSKK608AGFP.
The K608 residue of the fusion construct,
ectoMuSKGFP, was mutated as described for MuSKK608A. The resulting gene product has its ectodomain replaced by GFP and lacks kinase activity.
Rapsyn.
The 1A15 cDNA clone encoding mouse muscle 43K protein, rapsyn (Froehner, 1989), was obtained from Dr. S. Froehner (University of North Carolina, Chapel Hill, NC) and was subcloned in pRK7.
RapsynGFP.
The rapsynGFP expression vector was obtained from Dr. J. Cohen (Harvard Medical School, Boston, MA) (Ramarao and Cohen, 1998).
Agrin.
The vector containing neural agrin, cAgrin7A4B8 (Denzer et al., 1995) was provided by Dr. M. A. Ruegg (University of Basel, Basel, Switzerland).
Cre recombinase.
The Cre cDNA has a nuclear localization signal n and was excised by EcoRI and XbaI from pMC-Cre (Gu et al., 1993) and ligated into pRK5 to yield pRK5-nCre.
Transgenic mice
Homozygous MuSKloxP/loxP and heterozygous MuSKloxP/- mutant mice were generated by Dr. B.A. Hesser (Hesser, 2000; unpublished data). A genomic fragment of 6.3 kb that contained the MuSK kinase exon domain was cloned into pSP72 (Promega) and used for the construction of the targeting vector. In the introns flanking the kinase domain at the 5' and 3' end loxP sites were introduced. The targeting vector was introduced into embryonic stem cells and the resulting cell clones were injected into blastocysts derived from C57Bl/6J mice (at BRL Füllinsdorf, Switzerland).
Muscle fiber injection
Muscle fibers were injected as described previously (Jones et al., 1997; Sander et al., 2000). Sprague Dawley rats (rattus norvegicus) of
150 g body weight (45-wk-old) were anesthetized with Nembutal (Abbott Laboratories) at a dosage of 50 mg/kg. The soleus muscle of the left hind leg was surgically exposed. Micropipettes were filled with injection solution that consisted of 90 mM KCl, 15 mg/ml Fast Green FCF (Sigma-Aldrich) and each plasmid DNA at a concentration of 100 ng/µl. Air pressure pulses of 1 psi for 0.20.3 s were used to inject the DNA into individual muscle fibers. A reference electrode was used to measure the membrane potential of the injected fiber and injection was visualized directly by Fast Green FCF.
Histological analysis
3 or 4 wk after injection, animals were killed by CO2 to excise soleus muscles, which were kept in Ringer's solution (135 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5 mM Hepes) for further analysis. The muscles were pinned to Sylgard-lined plastic dishes and then incubated for 1 h at RT in 2 µg/ml r-bgt (Molecular Probes) in Ringer's solution. Labeled AChR and GFP fluorescence were viewed with a ZEISS Axioplan microscope.
AChE activity was visualized according to Koelle and Friedenwald (1949). The number of fibers expressing AChR clusters, nGFP, or GFP-tagged proteins (as applicable) was determined and compared with the total number of fibers initially injected.
For confocal microscopy, fluorescently labeled muscles were fixed for 3 min in PBS containing 4% paraformaldehyde. A thin layer of muscle fibers containing the regions of interest was prepared and mounted in CITIFLUOR onto high quality glass coverslips. Confocal image series were recorded on a Leica confocal laser scanning unit, TCS NT, which was coupled to a Leica DM IRB microscope. The image series were processed using the TCS NT software (Leica). For colocalization analysis, the original three-dimensional data were first deconvolved with the HUYGENS2 software (SVI; Hilversum) and then further processed with the CO-LOCALISATION module of the IMARIS 3D visualization program (Bitplane). Intensity values of corresponding individual voxels (volume pixels) of the green and the red fluorescence channel of a three-dimensional dataset were plotted as a two-dimensional graph (displaying occurrence of individual combinations of green fluorescence intensities, x-axis and red fluorescence intensities, y-axis). In situ hybridization was performed as detailed in Kues et al. (1995).
| Footnotes |
|---|
Andreas Sander's present address is Abbott GmbH Diagnostika, Max-Planck-Ring 2, D-65205 Wiesbaden-Delkenheim, Germany.
Boris Hesser's present address is Genentech, Inc., 1 DNA Way, MS # 60, South San Francisco, CA 94080-4990.
* Abbreviations used in this paper: AChE, acetylcholinesterase; AChR, acetylcholine receptor; Cre, Cre recombinase; GFP, green fluorescent protein; MuSK, muscle-specific receptor tyrosine kinase; r-bgt, rhodamine-labeled
-bungarotoxin. | Acknowledgments |
|---|
The work was supported by the Deutsche Forschungsgemeinschaft (SFB317).
Submitted: 7 May 2001
Revised: 31 October 2001
Accepted: 2 November 2001
| References |
|---|
|
|
|---|
Apel, E.D., D.J. Glass, L.M. Moscoso, G.D. Yancopoulos, and J.R. Sanes. 1997. Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold. Neuron. 18:623635.
Brenner, H.R., V. Witzemann, and B. Sakmann. 1990. Imprinting of acetylcholine receptor messenger RNA accumulation in mammalian neuromuscular synapses. Nature. 344:544547.
Burden, S.J. 1998. The formation of neuromuscular synapses. Genes. Dev. 12:133148.
Cohen, I., M. Rimer, T. Lomo, and U.J. McMahan. 1997. Agrin-induced postsynaptic-like apparatus in skeletal muscle fibers in vivo. Mol. Cell. Neurosci. 9:237253.
DeChiara, T.M., D.C. Bowen, D.M. Valenzuela, M.V. Simmons, W.T. Poueymirou, S. Thomas, E. Kinetz, D.L. Compton, E. Rojas, J.S. Park, et al. 1996. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell. 85:501512.
Denzer, A.J., M. Gesemann, B. Schumacher, and M.A. Ruegg. 1995. An amino terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix. J. Cell Biol. 131:15471560.
Froehner, S.C. 1989. Expression of RNA transcripts for the postsynaptic 43 kDa protein in innervated and denervated rat skeletal muscle. FEBS Lett. 249:229233.
Froehner, S.C., C.W. Luetje, P.B. Scotland, and J. Patrick. 1990. The postsynaptic 43K protein clusters muscle nicotinic acetylcholine receptors in Xenopus oocytes. Neuron. 5:403410.
Froehner, S.C. 1991. The submembrane machinery for nicotinic acetylcholine receptor clustering. J. Cell Biol. 114:17.
Gautam, M., P.G. Noakes, J. Mudd, M. Nichol, G.C. Chu, J.R. Sanes, and J.P. Merlie. 1995. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature. 377:232236.
Gautam, M., P.G. Noakes, L. Moscoso, F. Rupp, R.H. Scheller, J.P. Merlie, and J.R. Sanes. 1996. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell. 85:525535.
Glass, D.J., D.C. Bowen, T.N. Stitt, C. Radziejewski, J. Bruno, T.E. Ryan, D.R. Gies, S. Shah, K. Mattsson, S.J. Burden, et al. 1996. Agrin acts via a MuSK receptor complex. Cell. 85:513523.
Glass, D.J., E.D. Apel, S. Shah, D.C. Bowen, T.M. DeChiara, T.N. Stitt, J.R. Sanes, and G.D. Yancopoulos. 1997. Kinase domain of the muscle-specific receptor tyrosine kinase (MuSK) is sufficient for phosphorylation but not clustering of acetylcholine receptors: required role for the MuSK ectodomain? Proc. Natl. Acad. Sci. USA. 94:88488853.
Gu, H., Y.R. Zou, and K. Rajewsky. 1993. Independent control of immunoglobulin switch recombinant at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell. 73:11551164.
Herbst, R., and S.J. Burden. 2000. The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. EMBO J. 19:6777.
Hesser, B.A. 2000. Isolierung und charakterisierung der muskel-spezifischen kinase "MuSK" und die etablierung eines neuren versuchssytems zur konditionalen expression von Musk in transgenen tieren. Ph.D. thesis. Ruprecht-Karls-Universität, Heidelberg. 144 pp.
Hesser, B.A., A. Sander, and V. Witzemann. 1999. Identification and characterisation of a novel splice variant of MuSK. FEBS Lett. 442:133137.
Hubbard, S.R., M. Mohammadi, and J. Schlessinger. 1998. Autoregulatory mechanisms in protein-tyrosine kinases. J. Biol. Chem. 273:1198711990.
Jones, G., T. Meier, M. Lichtsteiner, V. Witzemann, B. Sakmann, and H.R. Brenner. 1997. Induction by agrin of ectopic and functional postsynaptic-like membrane in innervated muscle. Proc. Natl. Acad. Sci. USA. 94:26542659.
Jones, G., C. Moore, S. Hashemolhosseini, and H.R. Brenner. 1999. Constitutively active MuSK is clustered in the absence of agrin and induces ectopic postsynaptic-like membranes in skeletal muscle fibers. J. Neurosci. 19:33763383.
Koelle, G.B., and J.S. Friedenwald. 1949. A histochemical method for localizing cholinesterase activity. Proc. Soc. Exp. Biol. Methods. 70:617622.
Kues, W.A., B. Sakmann, and V. Witzemann. 1995. Differential expression patterns of five acetylcholine receptor subunit genes in rat muscle during development. Eur. J. Neurosci. 7:13761385.
Lanford, R.E., R.G. White, R.G. Dunham, and P. Kanda. 1988. Effect of basic and nonbasic amino acid substitutions on transport induced by simian virus 40 T-antigen synthetic peptide nuclear transport signals. Mol. Cell. Biol. 8:27222729.
Lin, W., R.W. Burgess, B. Dominguez, S.L. Pfaff, J.R. Sanes, and K.-F. Lee. 2001. Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature. 410:10571064.
Morris, J.K., W. Lin, C. Hauser, Y. Marchuk, D. Getman, and K.-F. Lee. 1999. Rescue of the cardiac defect in erbB2 mutant mice reveals essential roles of erbB2 in peripheral nervous system development. Neuron. 23:273283.
McMahan, U.J. 1990. The agrin hypothesis. Cold Spring Harbor Symp. Quant. Biol. 55:407418.
Meier, T., D.M. Hauser, M. Chiquet, L. Landmann, M.A. Ruegg, and H.R. Brenner. 1997. Neural agrin induces ectopic postsynaptic specializations in innervated muscle fibers. J. Neurosci. 17:65346544.
Meier, T., F. Masciulli, C. Moore, F. Schoumacher, U. Eppenberger, A.J. Denzer, G. Jones, and H.R. Brenner. 1998. Agrin can mediate acetylcholine receptor gene expression in muscle by aggregation of muscle-derived neuregulins. J. Cell Biol. 141:715726.
Ramarao, M.K., and J.B. Cohen. 1998. Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn. Proc. Natl. Acad. Sci. USA. 95:40074012.
Phillips, W.D., C. Kopta, P. Blount, P.D. Gardner, J.H. Steinbach, and J.P. Merlie. 1991. ACh receptor-rich domains organized in fibroblasts by recombinant 43-kilodalton protein. Science. 251:568570.
Riethmacher, D., E. Sonnenberg-Riethmacher, V. Brinkmann, T. Yamaai, G.R. Lewin, and C. Birchmeier. 1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature. 389:725730.
Rimer, M., I. Mathiesen, T. Lomo, and U.J. McMahan. 1997.
-AChR/
-AChR switch at agrin-induced postsynaptic-like apparatus in skeletal muscle. Mol. Cell. Neurosci. 9:254263.
Sanes, J.R., and J.W. Lichtman. 1999. Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci. 22:389442.
Sander, A., A. Güth, H.R. Brenner, and V. Witzemann. 2000. Gene transfer into individual muscle fibers and conditional gene expression in living animals. Cell Tissue Res. 301:397403.
Schall, T.J., M. Lewis, K.J. Koller, A. Lee, G.C. Rice, G.H. Wong, T. Gatanaga, G.A. Granger, R. Lentz, H. Raab, et al. 1990. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 61:361370.
Schlessinger, J., and A. Ullrich. 1992. Growth factor signaling by receptor tyrosine kinases. Neuron. 9:383391.
Valenzuela, D.M., T.N. Stitt, P.S. DiStefano, E. Rojas, K. Mattsson, D.L. Compton, L. Nuñez, J.S. Park, J.L. Stark, D.R. Gies, et al. 1995. Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron. 15:573584.
Yang, X., W. Li, E.D. Prescott, S.J. Burden, and J.C. Wang. 2000. DNA topoisomerase IIß and neural development. Science. 287:131134.
Yang, X., S. Arber, C. William, Y. Tanabe, T.M. Jessell, C. Birchmeier, and S.J. Burden. 2001. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron. 30:399410.
Zhou, H., D.J. Glass, G.D. Yancopoulos, and J.R. Sanes. 1999. Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializations. J. Cell Biol. 146:11331146.
Zolotukhin, S., M. Potter, W.W. Hauswirth, J. Guy, and N.A. Muzyczka. 1996. "Humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:46464654.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|